Technology Offerings

Inhibitors of NO-synthases

The substances of the invention are highly effective low-molecular NO-synthases inhibitors. They can be synthesised easily and inexpensively in high purity via…

Improving Bioavailability

The amidine group is an essential component of many pharmacologically active agents. However, in general pharmaceutical compositions with one or more amidine…

Nasopharyngeal tube

Stops snoring and helps with sleeping apnoe.Further Information: PDF MBM ScienceBridge GmbHPhone: (0551) 30724-151ContactDr. Jens-Peter Horst

nSMase3: Novel neutral Sphingomyelinase and its use for diagnostics andtherapy with focus on heart muscle diseases and male fert

A novel human TNF-responsible neutral phingomyelinase enzyme (nSMase3) has been identified. Furthermore, the invention relates to the use of nSMase3 as…

Compo-Q: New small molecules for the treatment of prion and neurodegenerative diseases(e.g. Alzheimer’s disease)

Scientists at the University of Duesseldorf and the University of Erlangen have developed new small molecules which can be used for the treatment of diseases…

Ecto-NTPDase-Inhibitors

Inhibitors for use in human therapy Invention

The invention provides a new class of nucleosides

Page
1 447 448 449 450 451 518